In recent years BFC developed a EU-Market Access Program to support pharmaceutical companies with the marketing of pharmaceutical products. It includes all necessary elements for the launch of a pharmaceutical product on the Dutch or European market. These elements can consist of:
- Marketing authorization approval process
- Supply chain support and distribution strategy
- Additional licensing activities e.g. for opioid distribution
- Pricing & reimbursement applications
- Promotion and advertising compliance monitoring
- Pharmacovigilance systems including interfacing with EudraVigilance
- Post-Approval Committment implementations
In particular foreign companies, new to the Dutch pharmaceutical environment, may benefit significantly from such a program which will be tailored to the needs of the product and its company.